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Association between calcium intake, parathormone levels and
blood pressure during pregnancy*
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SUMMARY
Purpose: To evaluate the association between calcium intake from diet, calciotropic hormones (PTH, PTH-rp), vasoactive
regulators (endothelin, nitric oxide) and blood pressure levels during pregnancy, birth and puerperium.
Method: In a prospective study 149 healthy normotensive primigravidas were followed-up from 15 weeks of gestation to
puerperium. Daily calcium intake, calciuria, PTH, PTH-rp, endothelin, nitrite-nitrate, and Holter Test were assessed. Linear
regression models were performed to evaluate the association between calcium intake, blood pressure levels and the laboratory
tests. Multivariate regression models were performed to control potential confounders.
Results: A significant increase of calcium intake during pregnancy was observed (931±301 mg/day to 1,195±467 mg/day,
p<0.001). Plasma PTH-rp, endothelin, and nitrite-nitrate levels did not change during pregnancy. Among the women 38 (25.4%)
had low calcium intake (<800 mg/day) with a larger increase of systolic and diastolic blood pressure during pregnancy (p=0.04)
birth (p=0.006) and puerperium (p=0.01). After adjusting for other factors the multivariate analyses showed statistical
association between low calcium intake, high parathormone levels and high systolic blood pressure levels during pregnancy
(p=0.002).
Conclusion: Low calcium intake during pregnancy is associated with a larger increase of systolic blood pressure and high
parathormone levels.
Keywords: Calcium intake; Endothelin; PTH: PTH-rp: Preeclampsia; Nitric oxide.
Asociación entre consumo de calcio, niveles de parathormona y presión arterial en el embarazo
RESUMEN
Objetivo: Evaluar la asociación entre la ingesta de calcio en el embarazo, los niveles de presión arterial, las hormonas
calciotrópicas (PTH, PTH-rp) y sustancias vasorreguladoras (endotelina, óxido nítrico).
Métodos: Se realizó un estudio prospectivo con 149 primigrávidas normotensas que fueron incluidas en la semana 15 de
gestación con seguimiento y evaluación hasta el puerperio. Se evaluó la ingesta diaria de calcio, la monitoría Holter de 24 horas,
la calciuria, PTH, PTH-rp, la endotelina, nitritos y nitratos. Se siguieron modelos de regresión lineal para evaluar la asociación
entre la ingesta de calcio, la presión arterial, las hormonas calciotrópicas y los vasorreguladores. Para controlar las variables
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results were presented as an abstract at the World Congress of Obstetrics and Gynecology (FIGO), Kuala Lumpur,
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de confusión se hicieron modelos de regresión múltiple.
Resultados: Durante el embarazo la ingesta de calcio
aumentó significativamente (931±301 mg/día a 1,195±467 mg/
día, p<0.001). Entre las embarazadas 38 (25.4%) tuvieron una
baja ingesta de calcio (<800 mg/día) asociada con mayores
niveles de presión arterial sistólica y diastólica durante el
embarazo (p=0.04), en el parto (p=0.006) y en el puerperio
(p=0.01). Los mayores niveles de presión arterial sistólica
durante el embarazo se asociaron con mayores niveles de
paratormona y con menores niveles de ingesta de calcio
(p=0.002). Los niveles plasmáticos de PTH-rp, endotelina,
nitritos y nitratos no mostraron cambios durante el embarazo.
Conclusión: La baja ingesta de calcio en el embarazo se
asoció con mayores niveles de paratormona y de presión
arterial sistólica durante el embarazo.
Palabras clave: Ingesta de calcio; Endotelina; PTH;
PTH-rp; Preeclampsia; Óxido nítrico.
Preeclampsia is the first cause of maternal morbidity,
mortality and intrauterine growth restriction (IUGR)1.
In developing countries, a high proportion of the pregnant
women have IUGR associated with unexplained medical
factors1. Slight elevation of blood pressure, although
within clinical normotensive range, can alter uterine and
placental perfusion and influence fetal growth2. A high
calcium diet enhances vasodilation and reduces blood
pressure in experimental hypertension3,4 with suppresion
of the parathyroid hypertensive factor5. A low calcium
diet enhances vasoconstriction and increases PTH and
coronary artery disease6. Low calcium intake increases
the incidence of eclampsia and the supplementation in
high risk pregnant women can reduce preeclampsia
complications7. In non-pregnant women high levels of
serum PTH were associated with markedlly increased
blood pressure8. Jesspersen et al.9 suggested a role of
serum PTH on the regulation of blood pressure in
pregnant women. Jorde et al.2 reported an association
between low calcium intake, parathyroid hormone, and
blood pressure during pregnancy. The association
between calcium intake, calciotropic hormones and
blood pressure during the pregnancy, birth and
puerperium is not well studied. In an attemp to
corroborate and to extend conclusions from previous
studies2 results from a prospective study of the blood
pressure levels during pregnancy, birth, and puerperium
as well as the relationship with calcium intake from diet,
calciotropic hormones and vasoactive regulators for
gaining a better understanding of the pathophysiologic
mechanisms are here reported.
This study was approved by the Human Ethical
Committee of Universidad of Alcalá, Spain and Hospital
Príncipe de Asturias, Alcalá. All recruited pregnant
women were informed about general objectives of the
study and the informed consent was read and signed by
all recruited pregnant patients.
METHODS
A prospective study was performed from 15 weeks
of gestational age to puerperium period (at least 48
hours). All Spanish healthy primigravid women during
2005-2006 were screened and recruited in the Hospital
Universitario Príncipe de Asturias (Alcalá de Henares,
Madrid, España). Inclusion criteria (healthy primigravida,
single pregnancy, first prenatal visit at 15 weeks of
gestational age) and exclusion criteria (diastolic blood
pressure of 85 mm Hg or more at the antenatal visit,
personal history of hypertension, cardiovascular or re-
nal disease) were verified by a member of the research
team. The gestational age was determined according to
the date of the last menstrual period if the woman had
a regular (26-31) day cycle; otherwise an ultrasound
evaluation for the gestational age was performed. The
Institutional Human Ethical Committee approved this
survey. Eligible women who agreed to participate in the
study received verbal information about the research
and were requested to sign written informed consent
forms.
Upon enrollment, physicians completed a question-
naire including socio-demographic and obstetric
characteristics (age, race, residence, education, socio-
economic status, parity). The participants were recruited
at the first prenatal visit. The calcium nutritional inventory,
24-hour calciuria, creatinuria and proteinuria; routine
clinical and analytical parameters (hemoglobin,
hematocrit, creatinine, uric acid) as well as other special
parameters, such as calciotropic hormones (PTH, PTH-
rp) and vasoactive regulators (endothelin and nitrite-
nitrate) were evaluated.
A volume of 10 ml of whole peripheral blood was
obtained from each individual by venipuncture of the
antecubital vein at 15 weeks of gestational age and at 28
weeks of gestational age. Plasma was separated
immediately by centrifugation, fractionated into several
aliquots, and stored frozen at -80°C until analysis.
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Serum levels of endothelin were determined by
immunoradiometric assay (IRMA) (Nichol Institute
Diagnostics, San Clemente, CA, USA)10 using reagents
from Amersham Biosciences (Endothelin 1 ELISA
System, Buckinghamshire, UK). PTH, PTH-rp, nitrite-
nitrate serum levels were measured by using sequential
immunometric quimioluminiscent in solid phase assay,
for two sites (IRMA)11 and for Griess reaction after
nitrate reduction12, respectively. The instruments used
were Hitachi analyzer (917 model, Roche Diagnostics,
Japan), Immulite Diagnostic 2000 (Dipesa, DPC, Los
Angeles, CA, USA), Coulter STKS Analyzer (Coulter
Electronics Corporation. Florida, USA) and Colorimetric
Analyzer (Alexis Biochemical, San Diego, CA, USA).
The lowest detectable concentration for PTH was 1 pg/
ml and for nitrite-nitrate was 2.5 μmol/l. For para-
thormone laboratory tests the coefficients of variation,
within- and between- assay, were 6.3% and 8.8%,
respectively.
The calcium nutritional inventory was performed by
recording the last week’s diet as recomended by WHO13.
During 24 hours before the laboratory tests the diet was
free of nitrite and nitrate. All clinical and laboratory tests
were repeated at 28 weks of gestational age. Blood
pressure was verified with a standardized mercurial
sphygmomanometer at each prenatal visit (phase V
Korotoff method=diastolic pressure).
The mean values of two consecutive measurements
were used for analysis. At 28 weeks of gestational age,
blood pressure measurements were obtained via blood
pressure Holter test using the Mobil-o-Graph ABP
Control Numbed Cardiac Diagnostics (Sheffield, UK)
and was interpreted based on the MAPA technique
(WHO standardized method with reduced intra-assay
variability)14 by a blind independent researcher from the
Nephrology unit (Hospital Universitario Príncipe de
Asturias). All of the patients were followed up and
received the standard antenatal visits every month until
the 36th week of gestation and twice a month thereafter.
Maternal and neonatal complications were evaluated.
The sample size was calculated by convenience as
a pilot study to get a better understanding of physiologic
mechanisms between blood pressure levels, calcium
intake and vasoactive mediators. Means are presented
with their standard deviation. Differences between
continuous variables were evaluated with the two-tailed
t test and Anova for variables that were normally
distributed and the Kruskall-Wallis test for variables
that were not normally distributed. χ2 or Fischer exact
test (if the smallest value was under 5) was used to
analyze differences in categorical variables.
To facilitate the statistical analyses the pregnant
women were divided into three groups according to their
calcium basal intake: low calcium intake <800 mg/day,
normal calcium intake 800-1200 mg/day, and high calcium
intake >1200 mg/day15,16. Linear regression models
were performed between systolic, diastolic and mean
blood pressure (during pregnancy, birth, and puerperium)
(dependent variable) and independent variables (basal
calcium intake and laboratory tests). Multivariate
regression models were performed to control for potential
confusion. Correlation coefficients and their 95%
confidence intervals were calculated by using SPSS for
Windows statistical package (version 11.5). A p<0.05
was regarded as statistically significant.
RESULTS
A total of 174 healthy primigravid women at 15
weeks of gestational age were screened in two hospital
outpatient clinics. Among the screened women, 9 (5.1%)
were excluded for maternal pathology. A total of 16
(9.6%) patients were lost to follow-up and were excluded
from analysis. The final analysis was based on 149
women.
Socioeconomic status of the women evaluated
according to the National Department of Statistics
(range 1-4) was low (level 1) in 34 women (22.8%),
medium (level 2) in 42 (28.1%), high (level 3) in 38
(25.6%), and very high (level 4) in 35 (23.4%). All
women were literate, Spanish white, and living at the
urban area.
Women were on average 28.9±4.8 years of age.
Body Mass Index (BMI) was 24.3±4.1 on average, with
obesity (BMI >30) observed in 14 (9.4%) pregnant
women. Participants gained a mean of 12.6±5.4 kg
during pregnancy. A total of 24 (16.1%) women smoked
a median of 5 cigarettes/day (range 2-20). At birth the
mean gestational age was 39.1+1.6 weeks.
Physiological variations of mean blood pressure
throughout pregnancy were observed: 111.8/62.3±11.3/
7.2 mm Hg at inclusion, 114.2/63.4±10.8/7.3 mm Hg at
28 weeks, and 117.4/66.4±12.1/12.0 mm at 35 weeks,
120.9/69.2±14.6/11.3 mm at birth, and 115.9/65.8±11.8/
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9.3 mm Hg at puerperium. The mean 24-hour blood
pressure (daytime and nightime) reported by the Holter
Test at 28 weeks of gestational age was 104.89/
65.03±7.98/6.14 mm Hg. At inclusion the socio-
demographic characteristics were similar according to
the groups of daily calcium intake (low, normal, high)
(Table 1). The plasma calcium levels and PTH levels
had no differences in accordance with the daily calcium
intake groups (9.6±0.2 mg, 9.0±0.2 mg, 9.2±0.3 mg,
p=0.43) (26.9±13.3 pg/ml, 23.1±12.7 pg/ml, 23.4±13.8
pg/ml, p=0.73) respectively. The plasma calcium was
positively correlated with the calcium intake (r=0.87,
p=0.01).
At inclusion high calcium intake (HCI) (>1.200 mg/
day) was observed in 72 (48.2%) pregnant women,
normal calcium intake (NCI) (800-1,200 mg/day) in 39
(26.4%) and low calcium intake (LCI) (<800 mg/day) in
38 (25.4%) pregnant women. During the second trimester
the calcium intake increased (930.6±300.7 mg/day to
1195±467 mg/day, p<0.001) and PTH decreased without
changes on PTH-rp, endothelin and nitrite-nitrate levels
(Table 2). In all recruited pregnant women the calcium
intake was not correlated with systolic blood pressure
(p=0.53) nor with diastolic blood pressure (p=0.57). 24
hour urine volume and creatinuria increased (1,811±741
ml to 1,890±959 ml, p<0.01) (1,076±325 mg to 1,103±
280 mg). In contrast 24 hours calciuria decreased
(290.3±134 mg to 280.6±140 mg, p<0.001) without
differences on 24 hours proteinuria (107 mg range 0-600
to 168 mg range 0-522, p=0.56).
At third trimester the levels of hemoglobin, hematocrit,
creatinine and uric acid were normal and had no
differences according to daily calcium intake (Table 3).
The creatinine clearence was normal in all recruited
pregnant women (100.3±23.3). Creatinine clearance no
showed differences according to calcium intake (LCI:
99± 22, NCI: 102.2±19; HCI: 100.3±23.3; p=0.81).
In the group of women with low calcium intake was
observed the largest increase in diastolic blood pressure
during pregnancy (LCI median 7.80 mm Hg, range 3.01-
Table 1
Sociodemographic characteristics and daily basal calcium intake (n=149)
         Daliy calcium intake
                           Low (<800 mg) (n=38)   Normal (800-1.200 mg) (n=39)   High (>1.200 mg) (n=72)   p
 Age
 15-19 yrs old 1 (2.6) 2 (5.1)  2 (2.7)
 20-35 yrs old 36 (94.7) 35 (89.7)  69 (95.8)
 >35 yrs old 1 (2.6) 2 (5.1)  1 (1.4)  0.94
 Body Mass Index
 Malnutrition (<19) 2 (5.2) 3 (7.7) 5 (6.9)
 Normal (19-25) 27 (71.0) 26 (66.6) 51 (70.8)
 Overweight (>25-30) 7 (18.4) 8 (20.5) 12 (16.7)
 Obesity (>30) 2 (5.2) 2 (5.1)  4 (5.6)  0.78
 Socioeconomic status
 Low (Level 1) 3 (7.9) 11 (28.2) 11 (15.3)
 Medium (Level 2)  15 (39.5) 10 (25.6) 24 (33.3)
 High (Level 3) 15 (39.5) 9 (23.0) 24 (33.3)
 Very high (Level 4) 5 (13.1) 9 (23.0) 13(18.0)  0.77
 Educational level
 University  27 (71.0) 26 (66.6) 51 (70.8) 0.91
 Race
 Hispanic white 38 (25.4) 39 (26.4)  72 (48.2) 0.64
Data are presented as proportions n (%). Two-tailed t test was used to evaluate differences with normal distribution of data
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12.60; NCI median 5.62 mm Hg range 2.04-9.20; and
HCI median 0.94 mm Hg range -2.58 -4.47; p=0.04).
This group had a higher mean blood pressure at birth
compared to women with normal and high calcium
intake (123.5/73.5±15/10.2 mm Hg, 116.2/65.3±9.3/6.8
mm Hg, and 117.2/67.1±11.5/9.1 mm Hg, respectively;
p=0.006) (Graphics 1, 2). Women with low calcium
intake had the highest mean blood pressure at puerperium
(LCI 66.31±8.9 mm Hg, NCI 65.30±6.8 mm Hg, and
HCI 61.48±5.9 mm Hg) (Graphics 1, 2) (p=0.01).
During the third trimester, a weak negative correlation
between the levels of calcium intake and the increase of
the diastolic blood pressure was observed (r=-0.29, 95%
CI -0.42, -0.13, p=0.004). At puerperium the same
Table 3
Daily basal calcium intake and laboratory tests (n=149)
Daily calcium intake
     Low (n=38)       Normal (n=39)          High (n= 72)             p
Hemoglobin (g/l) 11.7 ± 1.2 11.7 ± 1.0 11.7 ± 0.9 0.98
Hematocrit (%)  34.6 ± 2.9 34.7 ± 3.3 34.7 ± 2.9  0.98
Creatinine (mg/dl)  0.72 ± 0.1  0.83 ± 01 0.78 ± 0.2 0.56
Uric acid (mg/dl)  3.95 ± 06 3.50 ± 03 3.62 ± 0.7  0.11
Data are presented as mean/SD. Two-tailed t test was used to evaluate differences
Calcium i ntake: Low <800 mg/day, Normal: 800-1,200 mg/day High: >1,200 mg/day
Table 2
Parathormone and vasoactive mediators during the pregnancy (n=149)
                                                                                             Gestational age
Laboratory tests               At inclusion      28 weeks                              p
 PTH (pg/ml)a 20.9 (4.0-61.0) 18.85 (1.0-81.0)  0.03
 PTH r-P (pg/ml)a 0.39 (0.01-4.34)  0.86 (0.01-4.34)  0.11
 Endothelin (ET 1, fmol/ l)a 1.26 (0.01-5.91) 1.78 (0.01-6.44)  0.28
 Nitrites-nitrates (μmol/l)a 10.23 (4.77-31.6) 10.99 (1.81-58.8)  0.46
                            Daily calcium intake
                                                      Low (n=38)   Normal (n=39)        High (n= 72)           p
 PTH (pg/ml)a (15 wks) 26.9 ±10  23.1±9  23.4± 10  0.60
 PTH (pg/ml)a (28 wks) 21.2 ± 9  21.7±10  21.9±9  0.84
 PTH r-P (pg/ml)a (15 wks) 11.8± 4 11.3±5 16.4±6  0.11
 PTH r-P (pg/ml)a (28 wks) 10.6± 5  8.1±4  8.7±3 0.30
 Endothelin (ET 1, fmol/ l)a (15 wks)  17.2±7 14.7±6 21.6±9  0.35
 Endothelin (ET 1, fmol/ l)a (28 wks)  12.0±5 13.5±6 15.4±7 0.70
 Nitrites-nitrates (μmol/l)a (15 wks)b 10.3± 2.8 9.9±4.2 11.1± 5.2 0.72
 Nitrites-nitrates (μmol/l)a (28 wks)b  10.4± 4.2 13.0± 6.4 11.9± 6.4 0.56
a.  Data are presented as median (range) (Kruskall-Wallis test to detect differences)
b.  Data are presented as mean±SD (two-tailed T test to detect differences)
190
Colombia Médica                  Vol. 40 Nº 2, 2009 (Abril-Junio)
Table 4
Perinatal outcome of 149 healthy pregnant women
Pregnancy-induced hypertensiona 11 (7.4)
Gestational hypertension (without proteinuria)a 9 (6.0)
Preeclampsia (>300 mg 24 h/proteinuria)a 2 (1.4)
Gestational diabetes (ACOG criteria)a 15 (10.1)
Urinary infection (>105 colony in urine culture) 1st trimestera 9 (6.0)
Urinary infection (>105 colony in urine culture) 3th trimestera 8 (5.3)
Premature rupture of membranesa 15 (10.1)
Cesarean sectiona 30 (20.1)
Preterm delivery (<37 weeks of gestational age)a 9 (6.0)
Arterial umbilical cord blood pHb 7.25 ± 0.07
Venous umbilical cord blood pHb 7.31 ± 0.07
Arterial PO2
c 15 (2.0-89.0)
Birth weight (g)b 3128 ± 488
Low birth weight (<2.500 g)a 9 (6.1)
Small for gestational age (<10th percentile)b 21 (14.0)
Neonatal APGAR 1st minuteb 8.6 ± 0.9
Neonatal APGAR 5thb 9.8 ± 0.04
Hypoglycemia-respiratory distressa 14 (9.4)
a. Data are presented as n (%)                       b. Data are presented as mean±SD
c. Data are presented as median (range)        ACOG: American College of Obstetricians and Gynecologists criteria (2005)
results were observed (calcium intake and the diastolic
blood pressure) (r=-0.25, 95% CI -0.39, -0.09, p=0.01).
The pregnant women who further developed
pregnancy-induced hypertension had high levels of PTH
during pregnancy (15 weeks: 27.2±13 pg/ml, 28 weeks:
27.7±15.3 pg/ml) in comparison to the levels of PTH in
pregnant women who remained normotensive
(24.0±13.3 pg/ml, 21.9±14.8 pg/ml) (p=0.01).
In multivariate analyses, a significant association
was determined among systolic blood pressure increase
during pregnancy and low calcium intake and high PTH
levels (regression coefficient 0.53 p=0.002). At birth,
significant association was observed among systolic
blood pressure, low calcium intake, and high PTH levels
(regression coefficient 0.51 p=0.001). A total of 32
pregnant women (21.5%) had maternal and perinatal
morbidity (Table 4). A small incidence of low birthweight
was observed (6.1%) but the incidence of small for
gestational age (<10th percentile) was high (14%)
(Table 4). Smoking and neonatal weight were negatively
correlated (r=-0.54, p=0.01). No correlation among
calcium intake (low, normal and high), blood pressure
levels, and intrauterine growth restriction1 (systolic:
-0.02, diastolic -0.04) was observed.
DISCUSSION
The women included in this prospective study were
healthy pregnant women confirmed by clinical
parameters, laboratory tests and 24-hour blood pressure
Holter Test. To maintain homogeneity of the sample and
control for potential biases, women with extreme
reproductive age, multiple pregnancy, and borderline
high blood pressure, cardiovascular and renal disease
were excluded from the study.
The association between calcium intake and
parathormone levels and blood pressure levels in non
pregnant and pregnant women was described
elsewhere2,4,7-9. As far it is known this is the first report
about the relation between calcium intake and blood
pressure levels during pregnancy, birth and puerperium
with evaluation of calciotropic hormones and vasoactive
mediators. In this study an association between low
calcium intake in pregnant women and blood pressure
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levels during the perinatal period (pregnancy, birth and
puerperium) (p=0.01) was observed (Graphics 1, 2).
During pregnancy, there is a great demand for
calcium intake to respond to the higher demands caused
by the process of fetal bone formation. Furthermore,
there is a dilution of the cation due to the expansion of
the extracellular fluid volume, and to the normal hyper-
calciuria of pregnancy, consequent to increased
glomerular filtration. Thus, serum-ionized calcium
concentrations depend on adequate calcium intake7. In
this study, calcium nutrient intake, was initially normal
and increased during pregnancy according to nutritional
habits of women in developed countries. Calcium
homeostasis appears to be attained by more efficient
intestinal calcium absorption during pregnancy and by
renal conservation. PTH seems to play major roles in the
adjustment of calcium metabolism15. In this study calcium
intake was positively correlated to plasma calcium
levels indicating that calcium from diet was well absor-
bed and the creatinine clearance was normal indicating
a good renal function. The lack of association between
calcium intake and blood pressure in the second trimester
was observed in all recruited pregnant women probably
associated with good calcium intake observed in 74.6%
of the recruited pregnant women.
At inclusion there were no differences between
calcium intake and PTH levels. During the second
trimester calcium intake increased with subsequent
decrease of PTH, 24 hours calciuria and blood pressure.
Calcium is crucial for the production of endothelial
vasodilators like prostacyclin and nitric oxide8,16. In
addition, preeclamptic patients have low levels of serum-
ionized calcium and abnormal levels of calciotropic
hormones8. In this study PTH levels in pregnant women
Graphic 1. Systolic blood pressure during the perinatal period by calcium intake
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who further developed pregnancy-induced hypertension
were high in comparison with women who remained
normotensive (p=0.01) as was described before5. This
result is consistent with the hypothesis that the PTH is
a mediator between the calcium intake and the
hypertensive disorders of pregnancy7. A high calcium
diet enhances vasodilation and reduces blood pressure3,4
by suppresion of the parathyroid hypertensive factor5 in
contrast a low calcium diet enhances vasoconstriction
and increases PTH7 as was confirmed in this study. In
this study the only assessed vasoactive mediator
associated with blood pressure levels and calcium intake
was PTH, endothelin and nitric oxide production remained
normal.
The incidence of smoke habit and IUGR was high
(Table 4). This habit has been associated to IUGR and
to low birth weight as confirmed in this and other
studies17. Recent studies have shown that pregnant
women destined to develop preeclampsia have early
endothelial dysfunction with higher blood pressure levels,
although within clinical normotensive range18. When
PTH levels are persistently high5, women have high
systolic and diastolic blood pressure. In this study, after
adjusting for confounding factors, low calcium intake
was associated to high PTH levels and large increase of
systolic blood pressure during pregnancy. Slightly high
levels of blood pressure can alter uterine and placental
perfusion and determine fetal growth restriction2, a
serious condition with implications on the health of
newborns19. Further large clinical studies are needed to
test the clinical implications of the results of this
prospective study.
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